Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

BioLineRx Ltd. (BLRX) had Revenue of $0.29M for the most recently reported fiscal quarter, ending 2026-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2026-06-30

Income Statement Financials
Revenue	$0.29M
Net Income	$-3.03M
Cost of Goods Sold	$0.06M
Gross Profit	$0.23M
Operating Expenses	$3.87M
Operating Income	$-3.57M
Non-Operating Income/Expense	$-0.77M
Pre-Tax Income	$-4.34M
Normalized Pre-Tax Income	$-4.34M
Income after Taxes	$-4.34M
Income from Continuous Operations	$-4.34M
Consolidated Net Income/Loss	$-4.34M
Normalized Income after Taxes	$-4.34M
EBIT	$-3.57M
EBITDA	$-3.50M
Weighted-Average Shares Outstanding (Basic)	4.44M
Weighted-Average Shares Outstanding (Diluted)	4.44M
Earnings per Share (EPS) (Basic)	$0.00
Earnings per Share (EPS) (Diluted)	$0.00
Balance Sheet Financials
Current Assets	$16.35M
Property, Plant, and Equipment	$0.13M
Long-Term Assets	$17.13M
Total Assets	$33.48M
Current Liabilities	$13.68M
Long-Term Debt	$2.22M
Long-Term Liabilities	$3.18M
Total Liabilities	$16.86M
Common Equity	$16.62M
Tangible Shareholders Equity	$0.29M
Shareholders Equity	$16.62M
Common Shares Outstanding	4.37M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$-5.50M
Cash Flow from Investing Activities	$9.05M
Cash Flow from Financial Activities	$-2.32M
Beginning Cash	$3.25M
End Cash	$4.63M
Increase/Decrease in Cash	$1.38M
Stock-Based Compensation	$0.16M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.20
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.12
Debt to Equity Ratio	0.40
Gross Margin	79.93%
Operating Margin	-1215.31%
EBIT Margin	-1215.31%
EBITDA Margin	--
Pre-Tax Profit Margin	-1475.85%
Profit Margin	-1029.25%
Free Cash Flow	$-5.49M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.01
Inventory Turnover	0.03
Receiveable Turnover	0.40
Days Sales in Receivables	222.86
Return on Equity	-26.11%
Return on Tangible Equity	-1491.06%
Return on Assets	-12.96%
Return on Investments	-23.03%
Book Value Per Share	$3.80
Free Cash Flow per Share	$-1.24
Operating Cash Flow per Share	$-1.24

Data from Zacks Investment Research, Inc.